Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

ILMN

Illumina Inc

Sep 12 • 04:00PM ET

95.12

-4.19 -4.22 %

Healthcare • Diagnostics & Research • USA • NASD

Peers: PACB VRTX TXG QGEN GH BIO MYGN IONS TWST OMIC

| Held by: IJH VTI VB VBR VXF ARKK MDY IBB SPMD IWR

Scroll to Statements

Index	-	P/E	12.05	EPS (ttm)	7.90	Insider Own	2.78%	Shs Outstand	154.00M	Perf Week	-3.85%
Market Cap	14.62B	Forward P/E	19.69	EPS next Y	4.83	Insider Trans	0.43%	Shs Float	149.43M	Perf Month	-5.92%
Enterprise Value	16.06B	PEG	1.21	EPS next Q	1.17	Inst Own	102.34%	Short Float	4.83%	Perf Quarter	7.93%
Income	1.26B	P/S	3.41	EPS this Y	8.44%	Inst Trans	-0.41%	Short Ratio	3.64	Perf Half Y	13.17%
Sales	4.28B	P/B	6.49	EPS next Y	7.07%	ROA	20.68%	Short Interest	7.22M	Perf YTD	-28.82%
Book/sh	14.66	P/C	12.66	EPS next 5Y	9.92%	ROE	68.11%	52W High	156.66 -39.28%	Perf Year	-23.37%
Cash/sh	7.51	P/FCF	14.18	EPS past 3/5Y	- -	ROIC	29.41%	52W Low	68.70 38.46%	Perf 3Y	-52.43%
Dividend Est.	-	EV/EBITDA	11.20	Sales past 3/5Y	-1.15% 4.29%	Gross Margin	67.14%	Volatility	3.27% 2.72%	Perf 5Y	-71.41%
Dividend TTM	-	EV/Sales	3.75	EPS Y/Y TTM	141.36%	Oper. Margin	27.00%	ATR (14)	3.13	Perf 10Y	-49.92%
Dividend Ex-Date	-	Quick Ratio	1.41	Sales Y/Y TTM	-3.32%	Profit Margin	29.38%	RSI (14)	43.27	Recom	2.46
Dividend Gr. 3/5Y	- -	Current Ratio	1.81	EPS Q/Q	111.97%	SMA20	-3.82%	Beta	1.42	Target Price	111.10
Payout	-	Debt/Eq	1.15	Sales Q/Q	-4.95%	SMA50	-4.38%	Rel Volume	0.76	Prev Close	99.31
Employees	10370	LT Debt/Eq	0.89	Earnings	Jul 31 AMC	SMA200	-6.55%	Avg Volume	1.98M	Price	95.12
IPO	Jul 28, 2000	Option/Short	Yes / Yes	EPS/Sales Surpr.	17.59% 0.78%	Trades		Volume	1,516,412	Change	-4.22%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-12-25	Downgrade	Daiwa Securities	Outperform → Neutral	$94
Jul-11-25	Downgrade	Scotiabank	Sector Outperform → Sector Perform	$125
Mar-04-25	Reiterated	Citigroup	Neutral	$130 → $90
Feb-28-25	Downgrade	HSBC Securities	Buy → Hold	$100
Feb-10-25	Downgrade	Barclays	Equal Weight → Underweight	$130 → $100
Feb-07-25	Downgrade	TD Cowen	Buy → Hold	$177 → $140
Dec-11-24	Downgrade	Citigroup	Buy → Neutral	$190 → $165
Nov-12-24	Resumed	Morgan Stanley	Equal-Weight	$156
Oct-17-24	Upgrade	HSBC Securities	Hold → Buy	$180
Aug-28-24	Upgrade	Argus	Hold → Buy
Aug-16-24	Upgrade	Daiwa Securities	Neutral → Buy	$120 → $154
Aug-14-24	Upgrade	TD Cowen	Hold → Buy	$126 → $144
Aug-14-24	Upgrade	Barclays	Underweight → Equal Weight	$125
Jul-10-24	Upgrade	Citigroup	Neutral → Buy	$140
Jun-03-24	Resumed	Jefferies	Hold	$115
Jan-16-24	Downgrade	HSBC Securities	Buy → Hold
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$144
Dec-18-23	Upgrade	Scotiabank	Sector Perform → Sector Outperform	$185
Dec-15-23	Upgrade	Bernstein	Underperform → Mkt Perform
Dec-14-23	Initiated	Stephens	Overweight	$170

Show Previous Ratings

Sep-12-25 04:00PM	Why Illumina (ILMN) Stock Is Falling Today (StockStory)
Sep-09-25 08:04AM	ILMN Stock to Gain From the Launch of Illumina Protein Prep Assay (Zacks)
Sep-08-25 12:02AM	Illumina (ILMN): Buy, Sell, or Hold Post Q2 Earnings? (StockStory)
Sep-03-25 11:30AM	CRISPR Therapeutics (CRSP) Down 5.3% Since Last Earnings Report: Can It Rebound? (Zacks)
09:15AM	Illumina Protein Prep launches to drive greater proteomic insights for improved drug discovery and development (PR Newswire)
09:50AM	Loading…
Sep-01-25 09:50AM	Why Illumina (ILMN) is a Top Momentum Stock for the Long-Term (Zacks)
Aug-31-25 11:35PM	Life Sciences Tools & Services Stocks Q2 Results: Benchmarking Illumina (NASDAQ:ILMN) (StockStory)
Aug-18-25 09:00AM	Press Release Biocartis NV: Biocartis Welcomes Mike Kreitzinger as Senior Vice President of Global Business Development (GlobeNewswire)
Aug-15-25 09:15AM	TMO Receives FDA Approval for Oncomine Dx Target Test (Zacks)
Aug-14-25 04:01PM	BioStem Technologies Appoints Brandon Poe as Chief Financial Officer (GlobeNewswire)
11:40AM	KMDA vs. ILMN: Which Stock Is the Better Value Option? (Zacks)
Aug-13-25 09:50AM	Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
07:30AM	[Latest] Global AI in Synthetic Biology Market Size/Share Worth USD 192.95 Billion by 2034 at a 28.63% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) (GlobeNewswire)
12:22AM	Illumina's Q2 Earnings Call: Our Top 5 Analyst Questions (StockStory)
12:17AM	ILMN Q2 Deep Dive: Clinical Demand Cushions Revenue Decline Amid Research Weakness and Margin Pressures (StockStory)
10:30PM	Loading…
Aug-12-25 10:30PM	[Latest] US Personalized Medicine Market Size/Share Worth USD 252.93 Billion by 2034 at a 17.32% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis) (GlobeNewswire)
04:02PM	GRAIL Reports Second Quarter 2025 Financial Results (PR Newswire)
05:32AM	US Personalized Medicine Market Trends and Company Analysis Report 2025-2033 Featuring Abbott, GE, Aadi Bioscience, Illumina, QIAGEN, Eli Lilly and Co, Takeda, AbbVie, F. Hoffmann-La Roche (GlobeNewswire)
Aug-11-25 04:01PM	Standard BioTools Reports Second Quarter 2025 Financial Results (GlobeNewswire)
Aug-05-25 09:15AM	Illumina (ILMN) Reliance on International Sales: What Investors Need to Know (Zacks)
09:04AM	Does Illumina (ILMN) have an Attractive Risk-Reward Opportunity for Long-Term Investors? (Insider Monkey)
Aug-02-25 10:00AM	Illumina: Will big Pharma come to its rescue? Its CEO thinks so. (Yahoo Finance)
Aug-01-25 02:17PM	Top Technology Executives Recognized at the 2025 Minnesota ORBIE Awards (GlobeNewswire) -7.84%
12:20PM	Why Illumina (ILMN) Shares Are Falling Today (StockStory)
09:37AM	Analyst Report: Illumina, Inc. (Morningstar Research)
07:08AM	DOJ reaches $9.8 million settlement with Illumina over cyber whistleblower claims (Cybersecurity Dive)
Jul-31-25 07:00PM	Illumina: A 5.2 Rating Amid Challenges and Opportunities (Motley Fool)
06:30PM	Compared to Estimates, Illumina (ILMN) Q2 Earnings: A Look at Key Metrics (Zacks)
05:35PM	Illumina (ILMN) Q2 Earnings and Revenues Surpass Estimates (Zacks)
05:02PM	Illumina (NASDAQ:ILMN) Surprises With Q2 Sales (StockStory)
04:38PM	Loading…
04:38PM	Illumina: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Illumina Reports Financial Results for Second Quarter of Fiscal Year 2025 (PR Newswire)
Jul-30-25 09:44AM	3 Genomics Stocks Worth Adding to Your Portfolio in 2025 (Zacks)
09:15AM	Gear Up for Illumina (ILMN) Q2 Earnings: Wall Street Estimates for Key Metrics (Zacks)
09:15AM	Illumina enhances flagship assay to accelerate access to comprehensive tumor profiling (PR Newswire)
Jul-29-25 11:07PM	Illumina (ILMN) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
Jul-28-25 12:01PM	Illumina (ILMN) Stock Is Up, What You Need To Know (StockStory)
10:00AM	CRISPR Therapeutics AG (CRSP) May Report Negative Earnings: Know the Trend Ahead of Q2 Release (Zacks)
08:50AM	How to Find Strong Medical Stocks Slated for Positive Earnings Surprises (Zacks)
06:48AM	Non-Invasive Prenatal Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Eurofins Scientific, F. Hoffmann-La Roche, Invitae, Illumina, Natera, Centogene, and Qiagen (GlobeNewswire)
Jul-25-25 10:53PM	Analyst Report: Illumina, Inc. (Morningstar Research)
07:30AM	Why Cathie Wood Is Loading Up on This Hot Growth Stock (And Should You?) (Barchart)
Jul-24-25 11:08AM	CorMedix (CRMD) Soars 5.1%: Is Further Upside Left in the Stock? (Zacks)
10:00AM	Illumina (ILMN) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
06:26AM	Cathie Wood's Bold AI and Genomics Playbooks Revealed (GuruFocus.com)
06:22AM	Cathie Wood Pours Millions into Nvidia and Biotech, Dumps Rocket Lab (GuruFocus.com)
Jul-23-25 10:35AM	Clinical Next Generation Sequencing Market Trends and Forecasts Report 2025-2032 \| Personalized Medicine and R&D Investments Propel Growth (GlobeNewswire)
Jul-22-25 08:50AM	Want Better Returns? Don't Ignore These 2 Medical Stocks Set to Beat Earnings (Zacks) +7.63%
Jul-18-25 04:09AM	Favorable Government Support Fuels Germany's Biotech Innovation and Commercialization: Market to Surpass USD 94 Billion by 2034 Led by QIAGEN, Thermo Fisher Scientific, Illumina and Roche (GlobeNewswire)
Jul-16-25 08:00AM	Brown Cancer Center - First In U.S. To Offer New Comprehensive Cancer Sequencing (PR Newswire)
Jul-15-25 11:40AM	HRMY vs. ILMN: Which Stock Should Value Investors Buy Now? (Zacks)
Jul-14-25 09:39AM	Agenus (AGEN) Surges 19.3%: Is This an Indication of Further Gains? (Zacks)
08:41AM	Tumor Profiling Market Growth Trends and Forecast Report 2025-2033: Tumor Profiling Market to Reach $26.56 Billion by 2033, Driven by Precision Oncology (GlobeNewswire)
Jul-12-25 09:40AM	CoreWeave initiated, Texas Instruments upgraded: Wall Streets top analyst calls (TipRanks)
Jul-11-25 09:38AM	CoreWeave initiated, Texas Instruments upgraded: Wall Street's top analyst calls (The Fly)
Jul-10-25 04:05PM	Illumina to Announce Second Quarter 2025 Financial Results on Thursday, July 31, 2025 (PR Newswire)
09:15AM	Illumina named to TIME's World's Most Sustainable Companies list for the second consecutive year (PR Newswire)
Jul-09-25 12:00PM	Why Illumina (ILMN) Shares Are Falling Today (StockStory)
09:39AM	Microsoft upgraded, Instacart initiated: Wall Street's top analyst calls (The Fly)
Jul-07-25 03:40PM	Illumina (ILMN) Stock Trades Down, Here Is Why (StockStory)
08:30AM	iRhythm Technologies Announces Board Member Retirements and New Director Appointments (GlobeNewswire)
Jul-03-25 01:34AM	5 Must-Read Analyst Questions From Illumina's Q1 Earnings Call (StockStory)
Jun-30-25 04:01AM	Proteomic Biomarker Analytics Market Forecast Report 2025: Proteomics Steps Up Where Genomics Falls Short (GlobeNewswire)
Jun-26-25 08:07AM	Illumina Stock May Benefit From New Agreement to Acquire SomaLogic (Zacks)
Jun-25-25 08:00AM	Avance Biosciences Launches NGS Center of Excellence in Houston (PR Newswire)
12:16AM	Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy (PR Newswire)
Jun-24-25 05:52PM	Illumina, Inc. (ILMN): A Bull Case Theory (Insider Monkey)
Jun-23-25 12:32PM	Illumina bets on proteomics with $425m SomaLogic purchase (Medical Device Network)
07:13AM	Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy (PR Newswire)
07:05AM	Standard BioTools Enters Next Phase of Transformation with Strategic Sale of SomaLogic to Illumina (GlobeNewswire)
06:58AM	Illumina to buy SomaLogic for up to $425M (MedTech Dive)
01:35AM	Canaccord Raises Price Target Of Illumina, Inc. (ILMN). (Insider Monkey)
Jun-20-25 11:40AM	ADRNY vs. CLX: Which Stock Is the Better Value Option? (Zacks)
11:40AM	SGIOY or ZTS: Which Is the Better Value Stock Right Now? (Zacks)
11:40AM	HMY or FNV: Which Is the Better Value Stock Right Now? (Zacks)
11:40AM	GOOS vs. IDEXY: Which Stock Is the Better Value Option? (Zacks)
11:40AM	FTRE vs. ILMN: Which Stock Should Value Investors Buy Now? (Zacks)
Jun-18-25 12:05AM	3 Reasons ILMN is Risky and 1 Stock to Buy Instead (StockStory)
Jun-15-25 04:00AM	QIAGEN and Incyte Announce Precision Medicine Collaboration to Develop Companion Diagnostics for Patients With Mutant CALR-expressing Myeloproliferative Neoplasms (MPNs) (Business Wire)
Jun-13-25 12:07PM	Tempus AI's Expanding Ties Boost Novel R&D Efforts and Market Reach (Zacks)
Jun-10-25 04:01PM	lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics (PR Newswire)
08:26AM	ILMN Q1 Earnings Call: Clinical Growth and Cost Actions Offset Research and China Headwinds (StockStory)
May-30-25 09:27AM	Illumina Introduces a New AI algorithm PromoterAI: Stock to Gain? (Zacks)
May-29-25 11:52PM	Illumina, Inc. (ILMN) Unveils AI Breakthrough for Rare Disease Diagnosis (Insider Monkey)
02:01PM	Illumina unveils PromoterAI, a groundbreaking algorithm to accelerate insights for rare disease diagnosis (PR Newswire)
07:37AM	Illumina widens access to cancer tests with Medicare and new CDx (Medical Device Network)
May-28-25 02:32PM	Stifel Affirms Buy Rating on Illumina (ILMN) Stock (Insider Monkey)
09:15AM	Illumina expands clinical oncology portfolio unlocking new standard of care and access to precision therapies (PR Newswire)
08:12AM	Illumina's TSO Comprehensive Earns Japan's Approval: Stock to Gain? (Zacks)
May-25-25 11:34PM	Life Sciences Tools & Services Stocks Q1 Recap: Benchmarking Illumina (NASDAQ:ILMN) (StockStory)
May-21-25 09:05AM	3 Top Genomics Stocks to Add to Your Portfolio in 2025 (Zacks) -5.75%
May-20-25 08:49AM	Illumina Stock to Gain From the Launch of New DRAGEN v4.4 Software (Zacks)
May-14-25 04:05PM	Illumina To Webcast Upcoming Investor Conference (PR Newswire)
07:43AM	Illumina, Inc. (ILMN): Among Small-Cap Healthcare Stocks Hedge Funds Are Buying (Insider Monkey)
May-13-25 09:16AM	Investing in Illumina (ILMN)? Don't Miss Assessing Its International Revenue Trends (Zacks)
09:15AM	Illumina DRAGEN v4.4 powers clinical oncology research and multiomic applications (PR Newswire)
May-10-25 10:57AM	Illumina price target lowered to $135 from $160 at Stifel (TipRanks)
May-09-25 10:56AM	SEC ends probe of Illuminas Grail acquisition (MedTech Dive)
09:10AM	Q1 2025 Illumina Inc Earnings Call (Thomson Reuters StreetEvents)
08:49AM	Illumina Q1 Earnings Top Estimates, Revenues Down Y/Y, Stock Dips (Zacks)

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Dhingra Ankur	SVP, Chief Financial Officer	May 12 '25	Buy	81.21	6,100	495,381	24,906	May 14 04:20 PM
Thaysen Jacob	Chief Executive Officer	May 12 '25	Buy	80.88	6,500	525,732	77,540	May 14 04:18 PM
Thaysen Jacob	Chief Executive Officer	May 13 '25	Buy	80.84	5,850	472,942	83,390	May 14 04:18 PM
JAKOB WEDEL CHRISTENSEN	Officer	May 06 '25	Proposed Sale	77.21	549	42,388		May 06 04:02 PM
ARNOLD FRANCES	Director	Feb 27 '25	Proposed Sale	93.48	120	11,218		Feb 27 11:07 AM
JAKOB WEDEL	Officer	Feb 18 '25	Proposed Sale	100.00	460	46,000		Feb 18 04:22 PM
PATRICIA L LECKMAN	Officer	Feb 18 '25	Proposed Sale	100.00	1,756	175,600		Feb 18 04:08 PM
CHARLES E. DADSWELL TRUST U/A/	Officer	Oct 14 '24	Proposed Sale	145.54	4,948	720,132		Oct 15 08:03 AM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ILMN

Illumina Inc

Upgrade your FINVIZ experience